CBD-infused products are endless: nutritional treats, meds for anxiety or joint health, creams for irritated skin.
And that’s just for your dog.
In the exploding market for all things cannabis and hemp related, items for your pet will push sales (in the U.S.) to $125 million by 2022. Sky’s the limit for the CBD-based ointments, medicines and nutritional products for you.
Legalized cannabis has given our country a global head start in all of this, and Canadian companies jockey for position as the cannabis industry, still young, continues its speed-of-light growth.
Thanks to the Hemp Act in Canada (and the Farm Act in the U.S.) the CBD market is changing dramatically.
Malik says it’s now possible to produce inexpensive CBD in Canada, “provided you know what you’re doing and have the right technology and ecosystem.”
“What excites us the most at Biome is that we can produce cannabis medicine — made in Canada — at an affordable price point,” he said. “That hasn’t been possible before.”
Biome has targeted certain areas to research, particularly drug-resistant epilepsy, Parkinson’s disease and other neurological disorders. The parents of children with drug-resistant epilepsy, Malik says, currently pay between $2,000 and $5,000 a month for legally sourced CBD-based medicines.